Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 299,873
  • Shares Outstanding, K 11,485
  • Annual Sales, $ 38,520 K
  • Annual Income, $ 9,630 K
  • 60-Month Beta 1.65
  • Price/Sales 7.93
  • Price/Cash Flow 45.75
  • Price/Book 5.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.17
  • Number of Estimates 1
  • High Estimate 0.17
  • Low Estimate 0.17
  • Prior Year 0.11
  • Growth Rate Est. (year over year) +54.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.64 +0.04%
on 02/26/20
28.43 -13.30%
on 02/21/20
-1.16 (-4.49%)
since 01/24/20
3-Month
21.47 +14.81%
on 11/27/19
28.43 -13.30%
on 02/21/20
+2.14 (+9.51%)
since 11/26/19
52-Week
16.68 +47.78%
on 07/15/19
29.80 -17.28%
on 04/26/19
-1.02 (-3.97%)
since 02/26/19

Most Recent Stories

More News
IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointment of Steven Kachelmeyer as Vice President of Regulatory Affairs and Quality Assurance

IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance, effective June 30, 2020 after leading the Company's regulatory...

IRMD : 24.65 (-5.59%)
Uptrend Call Working As Iradimed Corp Stock Rises 15.5% (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on July 30th, 2019 at $22.77. In approximately 7 months, Iradimed Corp has returned 15.48% as of today's recent price of $26.29.

IRMD : 24.65 (-5.59%)
IRadimed (IRMD) Tops Q4 Earnings Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 50.00% and -0.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

IRMD : 24.65 (-5.59%)
IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results

IRMD : 24.65 (-5.59%)
IRadimed (IRMD) Reports Next Week: Wall Street Expects Earnings Growth

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IRMD : 24.65 (-5.59%)
IRADIMED CORPORATION to Hold 2019 Fourth Quarter Financial Results Conference Call on February 6th

IRMD : 24.65 (-5.59%)
IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointment of MaryBeth Smith as Vice President of Worldwide Sales

IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company's commercial...

IRMD : 24.65 (-5.59%)
Uptrend Call Working As Iradimed Corp Stock Rises 3.9% (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on July 30th, 2019 at $22.77. In approximately 5 months, Iradimed Corp has returned 3.89% as of today's recent price of $23.65.

IRMD : 24.65 (-5.59%)
IRADIMED CORPORATION Completes CE Mark Renewal Process For Its MRI Compatible Patient Vital Signs Monitoring System

IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices and the only known provider of a non-magnetic intravenous ("IV") infusion...

IRMD : 24.65 (-5.59%)
Iradimed Corp Up 3.2% Since SmarTrend Uptrend Call (IRMD)

SmarTrend identified an Uptrend for Iradimed Corp (NASDAQ:IRMD) on July 30th, 2019 at $22.77. In approximately 4 months, Iradimed Corp has returned 3.18% as of today's recent price of $23.49.

IRMD : 24.65 (-5.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IRMD with:

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

2nd Resistance Point 26.80
1st Resistance Point 25.73
Last Price 24.65
1st Support Level 24.11
2nd Support Level 23.56

See More

52-Week High 29.80
Fibonacci 61.8% 24.79
Last Price 24.65
Fibonacci 50% 23.24
Fibonacci 38.2% 21.69
52-Week Low 16.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar